Danya Institute Inc.

Research

Surgeon General’s Latest Advisories

May 2023 This month, the Surgeon General released two new advisories. Our Epidemic of Loneliness and Isolation focuses on the powerful effects of social connection on our health. Social Media and Youth Mental Health examines the current evidence on the impacts of social media on the mental health of children and adolescents, and steps needed to ensure social […]


CDC’s Youth Risk Behavior Survey 2011-2021

EXECUTIVE SUMMARY The CDC Youth Risk Behavior Survey (YRBS) Data Summary & Trends Report: 2011–2021 provides the most recent surveillance data, as well as 10-year trends, on health behaviors and experiences among high school students in the United States (U.S.) related to adolescent health and well-being. These include sexual behaviors, substance use, suicidal thoughts and behaviors, experiences […]


Genetic links to SUDs

NIH NIDA Press Release New NIH study reveals shared genetic markers underlying substance use disorders Breakthrough findings could lead to more effective prevention and treatment strategies for multiple substance use disorders March 22, 2023 ©iStock/Ideabug By combing through genomic data of over 1 million people, scientists have identified genes commonly inherited across addiction disorders, regardless […]


FDA to Restrict Xylazine

From the FDA February 28, 2023 FDA Takes Action to Restrict Unlawful Import of Xylazine Agency Aims to Maintain Availability for Legitimate Use in Animals while Preventing Importation for Illicit Purposes Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage […]


SAMHSA’s N-SUMHSS

From SAMHSA National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities The N‑SUMHSS is a voluntary annual survey of all active substance use and mental health facilities in the United States, its territories, and D.C. The annual report presents findings on the general profile of […]


Marijuana & hallucinogen reach all time-high

From NIDA, August 22, 2022 | View original article. Marijuana and hallucinogen use among young adults reached all time-high in 2021 NIH-supported study also found past-month vaping levels rebound after early pandemic drop Marijuana and hallucinogen use in the past year reported by young adults 19 to 30 years old increased significantly in 2021 compared […]


Buprenorphine misuse decreases

NIDA News Release, October 15, 2021 Buprenorphine misuse decreased among U.S. adults with opioid use disorder from 2015-2019 Data from a nationally representative survey indicate that in 2019, nearly three-fourths of U.S. adults reporting buprenorphine use did not misuse the medication in the past 12 months. In addition, buprenorphine misuse among people with opioid use […]


Opioid Affected Births Rise

From HRSA. Nationwide Study Shows Continued Rise in Opioid Affected Births A new study conducted by researchers at the U.S. Department of Health and Human Services (HHS) shows that the rates of pregnant women diagnosed with opioid use disorder and of babies born with withdrawal symptoms increased from 2010-2017. The study, published today in JAMA  indicates that […]


Cocaine overdose deaths triple

From U.S. News & World Report Overdose Deaths From Cocaine Rising Dramatically by Steven Reinberg While opioids were grabbing the headlines, cocaine overdose deaths in the United States have marched upward, nearly tripling over five years, a new government report shows. After a period of stability, cocaine-induced deaths rose by about 27% per year, on […]


Substance use disorders linked to COVID-19 susceptibility

From NIH A National Institutes of Health-funded study found that people with substance use disorders (SUDs) are more susceptible to COVID-19 and its complications. The research, published today in Molecular Psychiatry, was co-authored by Nora D. Volkow, M.D., director of the National Institute on Drug Abuse (NIDA). The findings suggest that health care providers should closely monitor patients […]